WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013122621) OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/122621    International Application No.:    PCT/US2012/051086
Publication Date: 22.08.2013 International Filing Date: 16.08.2012
IPC:
A61K 31/202 (2006.01), A61K 45/06 (2006.01), A61P 9/00 (2006.01), A61K 9/48 (2006.01)
Applicants: PIVOTAL THERAPEUTICS, INC. [CA/CA]; Pivotal Therapeutics, Inc. 81 Zenway Blvd Unit 10 Woodbridge, Ontario L4H 0S5 (CA) (For All Designated States Except US).
JACKOWSKI, George [CA/CA]; (CA) (For US Only).
MACSWEENEY, Rachelle [US/CA]; (CA) (For US Only).
SHAIKH, Nisar [CA/CA]; (CA) (For US Only).
YANTHA, Jason [CA/CA]; (CA) (For US Only).
SCHINI-KERTH, Valerie [FR/FR]; (FR) (For US Only)
Inventors: JACKOWSKI, George; (CA).
MACSWEENEY, Rachelle; (CA).
SHAIKH, Nisar; (CA).
YANTHA, Jason; (CA).
SCHINI-KERTH, Valerie; (FR)
Agent: FERRIS H. LANDER, INC.; Ferris H. Lander, Inc. P.O. Box 31166 Palm Beach Gardens, Florida 33420 (US)
Priority Data:
PCT/US2012/025021 14.02.2012 US
13/584,466 13.08.2012 US
Title (EN) OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH
(FR) FORMULATIONS D'OMÉGA-3 POUR LE TRAITEMENT DE FACTEURS DE RISQUE POUR DES MALADIES CARDIOVASCULAIRES ET LA PROTECTION CONTRE LA MORT SUBITE
Abstract: front page image
(EN)A formulation for treating omega-3 fatty acid deficiency is disclosed containing about 90% or more omega 3 fatty acids by weight comprised of a combination of Eicosapentaenoic acid (EPA), Docosapentaenoic acid (DPA) and Docosahexaenoic acid (DHA) in a weight ratio of EPA: DHA of from 5.7 to 6.3, wherein the sum of the EPA, DHA and DPA comprise about 82% by weight of the total formulation and about 92% of the total omega 3 fatty acid content of the composition. EPA + DHA are about 80% of the total formulation and about 89% of the total omega 3 fatty acid content of the composition. The formulation may further contain specific amounts of arachidonic acid (AA) and of omega-3 fatty acids having 18 carbon atoms, including one or more of stearidonic acid (SDA) and alpha-linolenic acid (ALA).
(FR)L'invention concerne une formulation pour le traitement d'une carence en acides gras oméga-3 qui contient environ 90 % en poids ou plus d'acides gras oméga-3 comprenant une combinaison d'acide eicosapentaénoïque (EPA), d'acide docosapentaénoïque (DPA) et d'acide docosahexaénoïque (DHA) selon un rapport de poids EPA: DHA compris entre 5,7 et 6,3 ; la somme d'EPA, de DHA et de DPA comprenant environ 82 % en poids de la formulation totale et environ 92 % de la teneur totale en acides gras oméga-3 de la composition. L'EPA et le DHA représentent environ 80 % de la formulation totale et environ 89 % de la teneur totale en acides gras oméga-3 de la composition. La formulation peut en outre contenir des quantités spécifiques d'acide arachidonique (AA) et d'acides gras oméga-3 ayant 18 atomes de carbone, notamment un ou plusieurs acides parmi l'acide stéaridonique (SDA) et l'acide alpha-linolénique (ALA).
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)